FDA: More Choices Available for Diabetes Management

The US Food and Drug Administration (FDA) frequently issues Consumer Updates, which feature the very latest information on FDA-regulated products. For Dec. 1, the regulatory agency is highlighting diabetes management.

Do you have diabetes?
Do you notice that your blood glucose (sugar) levels rise or fall quickly?
Has your doctor prescribed insulin to treat your diabetes?
Are you comfortable with using a medical device?

If you answered yes to all of those questions, continuous glucose monitors (CGMs) and insulin pumps are tools that you and your health care professional might consider to assist you in achieving stable blood sugar levels.

Why managing blood sugar levels is important

Diabetes is caused by defects in the body’s ability to produce or use insulin — a hormone that controls blood sugar levels and helps convert food into energy. If the pancreas doesn't make enough insulin, or if the insulin that is produced does not function properly, a person’s blood sugar level becomes too high. Over time, that can lead to serious health problems, including:

  • heart attack
  • stroke
  • kidney disease
  • nerve damage
  • loss of toes or feet
  • digestive problems
  • blindness
  • gum problems and loss of teeth

Low blood sugar can also be dangerous, causing you to feel shaky or pass out.

Devices that can help you now

If you have diabetes, there are several types of devices that can help you keep your blood sugar level within safe ranges. Here are three options you and your healthcare provider may want to consider:

  • - an insulin pump, which is a computerized device that can deliver a steady flow of insulin, even while you sleep. FDA has cleared and approved many different insulin pumps. The pump, which is similar in size to a pager, is worn outside the body and is connected to a tube (catheter) that carries insulin from the pump to another tube (cannula) implanted just under the skin.
  • - a continuous glucose monitor (CGM), which uses sensors that measure glucose levels every five minutes in the fluid around your cells (interstitial fluid). The sensor readings, which are sent wirelessly to a receiver, show whether blood sugar levels are rising or falling. Blood glucose meters, which use drops of blood placed on test strips, are approved for use to monitor your blood sugar. The FDA has not yet approved CGM values alone to determine insulin dosing.

There are also CGM-enabled insulin pumps, which can communicate wirelessly with a CGM sensor. The sensor readings are displayed on the insulin pump screen instead of on a separate receiver, which enables the user to carry one less piece of equipment.

There are currently two FDA-approved, CGM-enabled insulin pumps: the Medtronic MiniMed, approved in April 2006, and the Animas Vibe System, which was approved on Nov. 25, 2014. The Animas Vibe System combines the DexCom G4 Platinum CGM with an Animas insulin pump. This approval gives consumers more choices in the types of CGMs that can be integrated wirelessly with an insulin pump.

“These devices are an important technological advance to address some of the challenges people with diabetes face in managing their blood sugar,” says Alberto Gutierrez, Ph.D., director of FDA’s Office of In Vitro Diagnostics and Radiological Health. “As they become better integrated with insulin pumps, CGMs can ease the daily burden of people with diabetes who juggle the use of multiple medical devices.”

The coming innovation: artificial pancreas

In addition, researchers are making significant progress towards the development of artificial pancreas device systems (APDS). These automated, closed-loop systems combine a continuous glucose monitor, an insulin infusion pump, and a “smart” system that monitors glucose levels in the body and automatically pumps appropriate doses of insulin when needed, with little or no input from the patient. The ideal APDS will be a system of devices that closely mimics the glucose-regulating function of a healthy pancreas. It will not only monitor glucose levels but also automatically adjust the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia).

Currently many investigational studies involved in the development of APDS are using sensor enabled pumps, including ones that integrate the G4 Platinum System, as a component. The availability of an insulin pump that is already compatible with the G4 Platinum system will make the development and approval of APDS that use this technology easier. The FDA will continue to prioritize the development of an APDS and will continue to keep you and health care professionals informed of developments.

Source: FDA Consumer Health Information

Get a Free Diabetes Meal Plan

Get a free 7-Day Diabetes Meal Plan from Constance Brown-Riggs who is a Registered Dietitian-Certified Diabetes Educator and who is also a national spokesperson for the American Dietetic Association.

Just enter in your email below to download your free Diabetes Meal Plan.

By clicking Submit, you agree to send your info to BattleDiabetes.com who, in addition to 3rd party partners, may contact you with updates, products and information and we agree to use it according to our privacy policy and terms and conditions.

More Articles

More Articles

Scientists have discovered that a single gene forms a common link between type 2 diabetes and...

Natural supplements like cinnamon extract and apple cider vinegar could hold the key to lowering blood sugar levels, according to a recent...

Natural supplements like cinnamon extract and apple cider vinegar could hold the key to lowering blood sugar levels, according to a recent...

Could a person's risk for type 2 diabetes be written in their genes?

According to a study recently published in ...

Women who frequently shift around their sleeping hours could have worse metabolic health outcomes than their peers who stick with a...

The presence of the hormone leptin may hinder prenatal development, which could explain the origin of type 2 diabetes, according to...

An analysis of fossilized Native American feces shows that our ancestors ate up to sixteen times the fiber that we do today, but our...

Managing diabetes is hugely challenging for people of any age, but a new study suggests that young people may suffer all the more....

Disruptions to the gut’s ecosystem could be a future symptom facing young children who take antibiotics, which makes them more susceptible...

Breastfeeding a newborn holds many benefits for mommy and baby; it reduces the baby's risk for colds and viruses, it helps his bones (and yours)...

Fans of the Dexcom G5 Mobile have something to smile about.

At yesterday's hearing with the U.S. Food and Drug...

If you start your day with a cup of tea and end it with a glass of red wine, your blood sugar may thank you.

At least that...

As medical experts continue to debate whether or not "healthy obesity" can even exist, one new study suggests that risk for heart disease...

For years, type 1 diabetics have been anxiously waiting for that medical marvel that can stop the constant injections: the artificial...

“Low-fat” has been the battle cry of the health-conscious for over ‌‌‌‌‌‌‌‌‌‌‌...